Get your most innovative therapies to market.

Negotiate, price, settle & manage complex deals more efficiently.

Who we are

PharmaCCX is a communications platform founded by leaders from pharma, payers, and fintech.

We leverage technology and data to help pharma and payers seamlessly manage the entire price negotiation, rebate, and deal management process for complex access agreements such as

What we do

combination therapies

indication-based pricing

gene therapy

value-based deals

& more

Complex pricing negotiations don’t have to take months, get stalled, or not happen at all.

Overcome the administrative bottleneck of mounting complex agreements and get a headstart on negotiations.

PharmaCCX’s Contingent Commitment Exchange allows you to express what you really want in a pricing agreement without disclosing important, proprietary information to other parties, unless a deal is reached.

You set contingent commitments (like reserve prices, price volume rebates, performance- or outcome-based provisions).

Our platform finds matches and lets you manage resulting agreements in one place.

Learn More

Confidently present your best offer knowing it won't be disclosed unless a deal is met

And that’s not all. Other benefits include:
Efficiently manage and scale complex deals
Unlock stalled access agreements
Seamlessly communicate with all sides of a negotiation
Remain compliant with European Competition Law
Get your most innovative therapies to market
Enable outcome- and value-based contracts
Improve outcomes for more patients
Facilitate seemingly impossible access agreements
PharmaCCX helped Roche and the government of Sweden price a combination oncology therapy in days.
Learn More

Expert leadership team

We intimately understand your unique challenges and tailormade a solution based on our own needs. With a combined 80 years experience in pharma, finance, business, and tech, our leadership team is poised to help you save more patients’ lives by increasing their access to promising therapies.

Nathan Sigworth
Co-Founder & CEO

A health-tech entrepreneur who formerly co-founded and was CEO of PharmaSecure, which uses serialization to prevent counterfeit drugs from entering the global pharmaceutical supply chain.

Richard Bergstrom
Co-Founder & Customer Development

A chief lobbyist for the pharma industry in Europe, Sweden’s COVID-19 vaccine coordinator, and former Director General of EFPIA and LIF. He also worked in regulatory affairs at Roche and Novartis.

Carole Longson
Special Counsel for Governance

Highly respected advisor for life science policy and health technology assessment, and former Executive Director of NICE, the National Institute for Health and Care Excellence.

Independent & unbiased

PharmaCCX is an independent, third-party technology platform. We are 100% focused on helping pharma and payers more efficiently reach access agreements so that patients can get the complex therapies they need to survive. We do not take sides — instead, we work collaboratively with all parties involved in a negotiation to help increase patient access to promising, life-saving therapies.